ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651752 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651752; 2) Community: the network communities that were significantly associated with the response to NSC 651752; 3) Molecule: the relationships between components within communities and NSC 651752; 4) MDR: the compounds that were significantly associated with the NSC 651752.

NSC Compound Enrichment Correlation
NSC 743265 Null 0.0273071169565314 0.072629881
NSC 743962 Null 0.0273071169565314 0.048944876
NSC 752331 (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0273071169565314 0.02815944
NSC 756233 GW435821X 0.0273071169565314 0.23686732
NSC 77810 Naphtho[1,2-b]quinolizinium, 9-methyl-, bromide 0.0273071169565314 -0.1381411
NSC 10848 Null 0.0273071169565318 -0.043044001
NSC 116878 Cardiac glycoside 0.0273071169565318 0.15075553
NSC 122291 o-Toluenesulfonyl fluoride, 5-[3-[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]ureido]-, monoethanesulfonate (8CI) 0.0273071169565318 0.35649711
NSC 351907 MASTOPARAN 0.0273071169565318 0.22474309
NSC 628939 Null 0.0273071169565318 0.1704657
Total:21  Current:10    [First] [Prev] [Next] [Last]